Dali Pharmaceutical Co. Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 162.038 million compared to CNY 229.385 million a year ago. Operating income was CNY 7.428 million compared to CNY 15.131 million a year ago. Net income was CNY 4.835 million compared to CNY 14.719 million a year ago. Basic earnings per share from continuing operations was CNY 0.022 compared to CNY 0.067 a year ago.